Heart Disease Clinical Trials in San Antonio

Showing 161-168 of 168 trials

Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)

NCT00141856

The primary objective of this telephonic heart failure specific patient education study is to assess the incremental clinical, psycho-social, and functional lifestyle benefits of the Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study) when added to standard care among veteran beneficiaries with a heart failure diagnosis. A secondary objective is to assess the impact of the Health E Heart Study on total system utilization costs.

Heart Failure, Congestive

US Department of Veterans Affairs420 participantsStarted Jun 2005

San Antonio, Texas, United States

TERMINATED< 1 mile

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

NCT00568009

This is a randomized, double-blind, placebo-controlled, multi-center, sequential cohort study in subjects with congestive heart failure (CHF) and impaired renal function who are on stable furosemide treatment (³ 40 mg daily). A total of 50 subjects will be randomized to each increasing dose level of SLV320 or placebo in a sequential fashion.

Congestive Heart Failure

Solvay Pharmaceuticals300 participantsStarted Oct 2007

Whittier, California, United States • Largo, Florida, United States • Miami, Florida, United States +69 more locations

Health E Heart Study (South Texas Veterans Health Care System Heart Failure Disease Management Program/Study)

Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function

Heart Disease Trials in Other Cities

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

ARISE - Aggressive Reduction of Inflammation Stops Events

Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease

Biomarkers in Acute Heart Failure

Other Conditions in San Antonio